When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications

Journal of Inherited Metabolic Disease

Volumn 20, Issue 2, 1997, Pages 214-226

  Simmonds, H A ^a   Duley, J A ^a   Fairbanks, L D ^a   McBride, M B ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FLUOROURACIL; PURINE; PYRIMIDINE;

ANAMNESIS; ANEMIA; AUTISM; CEREBRAL PALSY; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DRUG HYPERSENSITIVITY; EPILEPSY; FAILURE TO THRIVE; GOUT; HEARING IMPAIRMENT; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; INBORN ERROR OF METABOLISM; KIDNEY DISEASE; KIDNEY FAILURE; MUSCLE WEAKNESS; NEPHROLITHIASIS; PURINE METABOLISM; PYRIMIDINE METABOLISM; RECURRENT INFECTION; SCREENING; SIBLING; SYMPTOM;

BIOLOGICAL MARKERS; HUMANS; PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS; PURINES; PYRIMIDINES;

EID: 0030917749     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005308923168     Document Type: Conference Paper

References (29)